In the past five years, immunotherapy has transformed the approach to treating resectable lung cancer in both neoadjuvant and adjuvant settings. During this webinar, experts will explore the continued importance of radiation therapy in managing resectable lung cancer and highlight essential insights that thoracic surgeons need for daily practice.
Sponsored by AstraZeneca
Moderators
Nathaniel R. Evans III, MD
Thomas Jefferson University
Philadelphia, PA
There are so many ways in which we, as surgeons, lead teams—from our first day in practice, through the end of our careers. As we lead teams, we learn repeatedly that a cohesive and effective team works toward common goals, and that successful leaders inspire team members by elucidating and giving importance to those shared goals. But is having the same end goal enough?
This video is based on the Latin Heart Rounds webinar series on the current management of patients with tetralogy of Fallot, including neonates and on the current short and long term outcomes for this congenital heart disease. The entire webinar is available here.
Circulating tumor DNA (ctDNA) is a blood test that can be used to detect and monitor thoracic malignancies. It is being used to detect mutations, monitor for recurrence after surgery and other treatments, and can even be used in conjunction with screening to help identify malignancy. As the field continues to advance, it is crucial for thoracic surgeons, trainees, and healthcare providers to stay informed about the latest developments in ctDNA testing and its applications for thoracic patients.
In this webinar, experts discuss insights into the management of adult patients with congenital heart disease (ACHD). The panelists will discuss the current management landscape for these patients, as well as provide a broad glimpse into how the field is evolving. Topics include: common lesions encountered by both adult and pediatric cardiac surgeons, how ACHD cases are reported, and how critical care issues may impact the management of this patient population.
Moderators
Hani K. Najm, MD, MSc
Cleveland Clinic
Cleveland, OH
With the emerging evidence, the use of SAVR in the era of TAVR expansion has been heavily debated. This webinar focuses on the latest science showing the benefit of SAVR over TAVR and will cover several key scenarios that could benefit from SAVR.
Moderators
George Arnaoutakis, MD
University of Texas at Austin Dell Medical School
Austin, TX
Puja Kachroo, MD
Washington University Physicians
St. Louis, MO
Panelists
Tsuyoshi Kaneko, MD
Washington University Physicians
St. Louis, MO
This 8 in 8 session focuses on fast-tracking in CABG patients. The presentation examines incorporating elements of ERAS and other fast track principles, data regarding the safety and efficacy of fast tracking, and a real-world patient case.
Speaker
Alison F. Ward, MD, Emory University, Atlanta, GA
As physicians, we spend the first half of our adult lives being told to always say yes. The goal is to build that CV so you can make it to the next step. Set a foundation to show you have potential and you’ll get accepted to medical school. Show academic, research, and leadership promise to land that coveted residency spot.
On June 7-8, 2024, in Miami, more than 120 cardiothoracic surgeons and heart team members from around the world gathered for the third annual STS Coronary Conference. With a focus on the technical aspects of coronary surgery, attendees experienced case-based panel discussions, abstract sessions, practical tips and tricks, and interactive “How I Do It” video presentations featuring surgical techniques.
The two-day 2024 STS Coronary Conference brought together coronary surgery experts from throughout the world.
The two-day event covered a wide range of topics, including conduit selection and harvest, graft configuration, off- and on-pump CABG, and a stepwise approach to minimally invasive coronary surgery, from MIDCAB to advanced multivessel revascularization.
"Coronary surgery is a sub-specialty within cardiac surgery, so it’s important for future surgeons to be skilled in off-pump surgery, minimally invasive surgery, and traditional on-pump cross clamp surgical techniques,” said Chase Brown, MD, assistant professor of surgery at the University of Pennsylvania, and a course presenter. “Attendees were able to learn from experts leading the way in the field.”
"The most exciting things I learned about were the technical aspects of coronary sequential grafting," said cardiac surgery resident Dr. Kevin An from the University of Toronto. “It’s an area I’m interested in implementing into my practice.”
Here's what a few other attendees said about the Coronary Conference:
"I enjoyed the panel discussions at the end of each session – I learned as much from them as I did from each of the presentations."
"So many great presentations. I think the 'How to Prevent AKI After CABG' presentation by Dr. Daniel Engleman may have been my favorite."
"After attending the sessions, we will add certain changes in the steps for endoscopic harvesting of the saphenous vein, as well as measures to reduce and prevent sternal wound complications."
"In the future, I would like to see more perioperative content and learn how to implant an Impella 5.5."
"I really enjoyed the conference. It was worth coming to the US from Brazil to take the course."
"As a result of attending the conference, I would tend to perform MAG-TAG more often to more patients, use the skeletonization technique to decrease sternal wound infections, and practice the Y-T graft."
In this video in the 8 in 8 Series, Dr. Dwight Owen (Ohio State University) discussed advances in biomarker testing and neoadjuvant immunotherapy for resectable non-small cell lung cancer. The talk includes a look at the role of PD-L1 testing, peri-operative chemo-immunotherapy, and the importance of NGS testing for patients with actionable mutations.
